Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001510
Filing Date
2019-05-14
Accepted
2019-05-14 16:28:50
Documents
42
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-033119.htm 10-Q 228461
2 CERTIFICATION proteo_10q-ex3101.htm EX-31.1 9922
3 CERTIFICATION proteo_10q-ex3102.htm EX-31.2 9962
4 CERTIFICATION proteo_10q-ex3200.htm EX-32 5656
  Complete submission text file 0001683168-19-001510.txt   1269817

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20190331.xml EX-101.INS 132963
6 XBRL SCHEMA FILE pteo-20190331.xsd EX-101.SCH 15753
7 XBRL CALCULATION FILE pteo-20190331_cal.xml EX-101.CAL 31396
8 XBRL DEFINITION FILE pteo-20190331_def.xml EX-101.DEF 64014
9 XBRL LABEL FILE pteo-20190331_lab.xml EX-101.LAB 114215
10 XBRL PRESENTATION FILE pteo-20190331_pre.xml EX-101.PRE 100334
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 19823146
SIC: 2834 Pharmaceutical Preparations